BIO-TECHNE CORP (TECH) Stock Fundamental Analysis
NASDAQ:TECH • US09073M1045
57.52 USD
-0.73 (-1.25%)
At close: Feb 20, 2026
57.52 USD
0 (0%)
After Hours: 2/20/2026, 8:07:03 PM
Taking everything into account, TECH scores 6 out of 10 in our fundamental rating. TECH was compared to 58 industry peers in the Life Sciences Tools & Services industry. TECH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. TECH has a correct valuation and a medium growth rate. With these ratings, TECH could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
- In the past year TECH was profitable.
- In the past year TECH had a positive cash flow from operations.
- In the past 5 years TECH has always been profitable.
- TECH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of TECH (3.17%) is better than 74.14% of its industry peers.
- TECH has a Return On Equity of 3.98%. This is in the better half of the industry: TECH outperforms 74.14% of its industry peers.
- With an excellent Return On Invested Capital value of 9.52%, TECH belongs to the best of the industry, outperforming 87.93% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for TECH is below the industry average of 11.94%.
- The last Return On Invested Capital (9.52%) for TECH is above the 3 year average (9.00%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 3.98% | ||
| ROIC | 9.52% |
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
1.3 Margins
- With a decent Profit Margin value of 6.58%, TECH is doing good in the industry, outperforming 74.14% of the companies in the same industry.
- In the last couple of years the Profit Margin of TECH has declined.
- TECH's Operating Margin of 22.59% is amongst the best of the industry. TECH outperforms 93.10% of its industry peers.
- TECH's Operating Margin has been stable in the last couple of years.
- TECH has a Gross Margin of 66.60%. This is amongst the best in the industry. TECH outperforms 87.93% of its industry peers.
- TECH's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.59% | ||
| PM (TTM) | 6.58% | ||
| GM | 66.6% |
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TECH is destroying value.
- Compared to 1 year ago, TECH has less shares outstanding
- The number of shares outstanding for TECH has been increased compared to 5 years ago.
- Compared to 1 year ago, TECH has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 12.24 indicates that TECH is not in any danger for bankruptcy at the moment.
- TECH has a Altman-Z score of 12.24. This is amongst the best in the industry. TECH outperforms 96.55% of its industry peers.
- TECH has a debt to FCF ratio of 1.17. This is a very positive value and a sign of high solvency as it would only need 1.17 years to pay back of all of its debts.
- The Debt to FCF ratio of TECH (1.17) is better than 89.66% of its industry peers.
- TECH has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
- TECH's Debt to Equity ratio of 0.13 is fine compared to the rest of the industry. TECH outperforms 60.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 1.17 | ||
| Altman-Z | 12.24 |
ROIC/WACC0.88
WACC10.86%
2.3 Liquidity
- TECH has a Current Ratio of 4.54. This indicates that TECH is financially healthy and has no problem in meeting its short term obligations.
- TECH has a better Current ratio (4.54) than 72.41% of its industry peers.
- TECH has a Quick Ratio of 3.08. This indicates that TECH is financially healthy and has no problem in meeting its short term obligations.
- TECH's Quick ratio of 3.08 is in line compared to the rest of the industry. TECH outperforms 56.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.54 | ||
| Quick Ratio | 3.08 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 8.84% over the past year.
- TECH shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.25% yearly.
- The Revenue has been growing slightly by 1.64% in the past year.
- Measured over the past years, TECH shows a quite strong growth in Revenue. The Revenue has been growing by 10.55% on average per year.
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%
3.2 Future
- TECH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.61% yearly.
- Based on estimates for the next years, TECH will show a small growth in Revenue. The Revenue will grow by 7.10% on average per year.
EPS Next Y4.66%
EPS Next 2Y7.87%
EPS Next 3Y10.61%
EPS Next 5Y8.61%
Revenue Next Year0.56%
Revenue Next 2Y3.68%
Revenue Next 3Y5.76%
Revenue Next 5Y7.1%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 29.20 indicates a quite expensive valuation of TECH.
- Based on the Price/Earnings ratio, TECH is valued a bit cheaper than the industry average as 63.79% of the companies are valued more expensively.
- When comparing the Price/Earnings ratio of TECH to the average of the S&P500 Index (26.99), we can say TECH is valued inline with the index average.
- A Price/Forward Earnings ratio of 25.61 indicates a quite expensive valuation of TECH.
- TECH's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. TECH is cheaper than 68.97% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 28.02, TECH is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.2 | ||
| Fwd PE | 25.61 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as TECH.
- Based on the Price/Free Cash Flow ratio, TECH is valued a bit cheaper than the industry average as 63.79% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 40.35 | ||
| EV/EBITDA | 24.01 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TECH does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of TECH may justify a higher PE ratio.
PEG (NY)6.27
PEG (5Y)2.6
EPS Next 2Y7.87%
EPS Next 3Y10.61%
5. Dividend
5.1 Amount
- With a yearly dividend of 0.54%, TECH is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.10, TECH pays a better dividend. On top of this TECH pays more dividend than 94.83% of the companies listed in the same industry.
- With a Dividend Yield of 0.54, TECH pays less dividend than the S&P500 average, which is at 1.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.54% |
5.2 History
- The dividend of TECH has a limited annual growth rate of 0.11%.
- TECH has paid a dividend for at least 10 years, which is a reliable track record.
- The dividend of TECH decreased recently.
Dividend Growth(5Y)0.11%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
- TECH pays out 62.38% of its income as dividend. This is not a sustainable payout ratio.
- The dividend of TECH is growing, but earnings are growing more, so the dividend growth is sustainable.
DP62.38%
EPS Next 2Y7.87%
EPS Next 3Y10.61%
57.52
-0.73 (-1.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)05-05 2026-05-05/bmo
Inst Owners107.49%
Inst Owner Change4.03%
Ins Owners0.25%
Ins Owner Change1.58%
Market Cap9.00B
Revenue(TTM)1.22B
Net Income(TTM)79.96M
Analysts81.74
Price Target71.44 (24.2%)
Short Float %6.31%
Short Ratio4.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.54% |
Yearly Dividend0.32
Dividend Growth(5Y)0.11%
DP62.38%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.96%
Min EPS beat(2)-2.04%
Max EPS beat(2)3.95%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-2.04%
Max EPS beat(4)7.36%
EPS beat(8)6
Avg EPS beat(8)3.61%
EPS beat(12)6
Avg EPS beat(12)1.11%
EPS beat(16)7
Avg EPS beat(16)-2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-3.53%
Max Revenue beat(2)-0.04%
Revenue beat(4)0
Avg Revenue beat(4)-1.87%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)-0.04%
Revenue beat(8)3
Avg Revenue beat(8)-0.65%
Revenue beat(12)3
Avg Revenue beat(12)-1.76%
Revenue beat(16)4
Avg Revenue beat(16)-2.17%
PT rev (1m)0%
PT rev (3m)5.24%
EPS NQ rev (1m)-3.7%
EPS NQ rev (3m)-4.29%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.16%
Revenue NQ rev (1m)-1.44%
Revenue NQ rev (3m)-1.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.2 | ||
| Fwd PE | 25.61 | ||
| P/S | 7.4 | ||
| P/FCF | 40.35 | ||
| P/OCF | 36.09 | ||
| P/B | 4.47 | ||
| P/tB | 12.94 | ||
| EV/EBITDA | 24.01 |
EPS(TTM)1.97
EY3.42%
EPS(NY)2.25
Fwd EY3.9%
FCF(TTM)1.43
FCFY2.48%
OCF(TTM)1.59
OCFY2.77%
SpS7.77
BVpS12.85
TBVpS4.45
PEG (NY)6.27
PEG (5Y)2.6
Graham Number23.87
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 3.98% | ||
| ROCE | 11.53% | ||
| ROIC | 9.52% | ||
| ROICexc | 10.26% | ||
| ROICexgc | 25.36% | ||
| OM | 22.59% | ||
| PM (TTM) | 6.58% | ||
| GM | 66.6% | ||
| FCFM | 18.35% |
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
ROICexc(3y)9.68%
ROICexc(5y)10.59%
ROICexgc(3y)24.93%
ROICexgc(5y)34.08%
ROCE(3y)10.9%
ROCE(5y)11.68%
ROICexgc growth 3Y-19.18%
ROICexgc growth 5Y-3.96%
ROICexc growth 3Y-9.13%
ROICexc growth 5Y5.53%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
F-Score8
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 1.17 | ||
| Debt/EBITDA | 0.69 | ||
| Cap/Depr | 25.35% | ||
| Cap/Sales | 2.16% | ||
| Interest Coverage | 15.32 | ||
| Cash Conversion | 65.89% | ||
| Profit Quality | 278.92% | ||
| Current Ratio | 4.54 | ||
| Quick Ratio | 3.08 | ||
| Altman-Z | 12.24 |
F-Score8
WACC10.86%
ROIC/WACC0.88
Cap/Depr(3y)40.04%
Cap/Depr(5y)43.01%
Cap/Sales(3y)3.78%
Cap/Sales(5y)4.03%
Profit Quality(3y)188.66%
Profit Quality(5y)177.71%
High Growth Momentum
Growth
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
EPS Next Y4.66%
EPS Next 2Y7.87%
EPS Next 3Y10.61%
EPS Next 5Y8.61%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%
Revenue Next Year0.56%
Revenue Next 2Y3.68%
Revenue Next 3Y5.76%
Revenue Next 5Y7.1%
EBIT growth 1Y9.53%
EBIT growth 3Y-3.81%
EBIT growth 5Y11.98%
EBIT Next Year15.61%
EBIT Next 3Y13.34%
EBIT Next 5Y8.56%
FCF growth 1Y-1.07%
FCF growth 3Y-2.92%
FCF growth 5Y10.82%
OCF growth 1Y-9.8%
OCF growth 3Y-4.03%
OCF growth 5Y6.98%
BIO-TECHNE CORP / TECH FAQ
Can you provide the ChartMill fundamental rating for BIO-TECHNE CORP?
ChartMill assigns a fundamental rating of 6 / 10 to TECH.
What is the valuation status of BIO-TECHNE CORP (TECH) stock?
ChartMill assigns a valuation rating of 4 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Fairly Valued.
How profitable is BIO-TECHNE CORP (TECH) stock?
BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.
What is the financial health of BIO-TECHNE CORP (TECH) stock?
The financial health rating of BIO-TECHNE CORP (TECH) is 7 / 10.
Is the dividend of BIO-TECHNE CORP sustainable?
The dividend rating of BIO-TECHNE CORP (TECH) is 4 / 10 and the dividend payout ratio is 62.38%.